Time trends in tumour thickness vary in subgroups: Analysis of 6475 patients by age, tumour site and melanoma subtype

Melanoma Research

Volumn 19, Issue 1, 2009, Pages 24-30

  Baumert, Jens ^a,c   Schmidt, Michael ^b   Giehl, Kathrin A ^a   Volkenandt, Matthias ^a   Plewig, Gerd ^a   Wendtner, Clemens ^d   Schmid Wendtner, Monika Hildegard ^a,e  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY OF BONN   (Germany)

Author keywords

Cutaneous melanoma; Epidemiology; Prevention; Time trends; Tumour thickness

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARM; ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER PATIENT; CANCER PREVENTION; CONTROLLED STUDY; CUTAENOUS MELANOMA; FEMALE; FOOT; HEAD; HUMAN; HUMAN TISSUE; LEG; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MELANOMA; NECK; PRIORITY JOURNAL; THICKNESS; TREATMENT PLANNING; TREND STUDY; TRUNK; TUMOR VOLUME; UNIVERSITY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; GERMANY; HUMANS; LOGISTIC MODELS; MALE; MELANOMA; MIDDLE AGED; RISK FACTORS; SEX FACTORS; SKIN NEOPLASMS;

EID: 59549086946     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e32831c6fe7     Document Type: Article

References (36)

1. Koh HK. Cutaneous melanoma. N Engl J Med 1991; 325:171-182.
2. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents: Vol. VII. Lyon: IARC; 1998.
3. Dennis LK. Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. Arch Dermatol 1999; 135:275-280.
4. Hall HI, Miller DR, Rogers JD, Bewerse B. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 1999; 40:35-42.
5. Marrett LD, Nguyen HL, Armstrong BK. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996. Int J Cancer 2001; 92:457-462.
6. De Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer 2003; 107:119-126.
7. La Vecchia C, Lucchini F, Negri E, Levi F. Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age. Int J Cancer 1999; 81:62-66.
8. Severi G, Giles GG, Robertson C, Boyle P, Autier P. Mortality from cutaneous melanoma: evidence for contrasting trends between populations. Br J Cancer 2000; 82:1887-1891.
9. Stang A, Stabenow R, Eisinger B, Jockei KH. Site- and gender-specific time trend analyses of the incidence of skin melanomas in the former German Democratic Republic (GDR) including 19351 cases. Eur J Cancer 2003; 39:1610-1618.
10. Balch CM, Murad TM, Soong SJ, Ingalls AL, Halpern NB, Maddox WA. A multifactorial analysis of melanoma: prognostic histopathological features comparing dark's and Breslow's staging methods. Ann Surg 1978; 188:732-742.
11. Garbe C, Buttner P, Bertz J, Burg G, d'Hoedt B, Drepper H, et al. Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer 1995; 75:2484-2491.
12. Buettner PG, Leiter U, Eigentier TK, Garbe C. Development of prognostic factors and survival in cutaneous melanoma over 25 years: an analysis of the Central Malignant Melanoma Registry of the German Dermatological Society. Cancer 2005; 103:616-624.
13. MacKie RM, Hole D. Audit of public education campaign to encourage earlier detection of malignant melanoma. Br Med J 1992; 304: 1012-1015.
14. Hoffmann K, Dirschka T, Schatz H, Segerling M, Tiemann T, Hoffmann A, et al. A local education campaign on early diagnosis of malignant melanoma. Eur J Epidemiol. 1993; 9:591-598.
15. MacKie R, Hunter JA, Aitchison TC, Hole D, Mclaren K, Rankin R, et al. Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group. Lancet 1992; 339:971-975.
16. Cavalieri R, Macchini V, Mostaccioli S, Sonego G, Ferranti G, Corona R, et al. Time trends in features of cutaneous melanoma at diagnosis: central-south Italy, 1962-1991. Ann 1st Super Sanita 1993; 29:469-472.
17. Thorn M, Ponten F, Bergstrom R, Sparen P, Adami HO. Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden. Br J Cancer 1994; 70:743-748.
18. Garbe C, McLeod GR, Buettner PG. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 2000; 89:1269-1278.
19. MacKie RM, Bray CA, Hole DJ, Morris A, Nicolson M, Evans A, et al. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet 2002; 360:587-591.
20. MacKie RM, Bray C, Vestey J, Doherty V, Evans A, Thomson D, et al. Melanoma incidence and mortality in Scotland 1979-2003. Br J Cancer 2007; 96:1772-1777.
21. Schmid-Wendtner MH, Baumert J, Eberle J, Plewig G, Volkenandt M, Sander CA. Disease progression in patients with thin cutaneous melanomas (tumour thickness < 0.75mm): clinical and epidemiological data from the Tumour Center Munich 1977-98. Br J Dermatol 2003; 149:788-793.
22. McCullagh P, Nelder JA. Generalized linear models. London: Chapman and Hall; 1989.
23. Burton RC, Armstrong BK. Non-metastasizing melanoma? J Surg Oncol 1998; 67:73-76.
24. Downing A, Yu X Q, Newton-Bishop J, Forman D. Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003. Int J Cancer 2008; 123:861-866.
25. Marks R. Two decades of the public health approach to skin cancer control in Australia: why, how and where are we now? Australas J Dermatol 1999; 40:1-5.
26. Blum A, Brand CU, Ellwanger U, Schlagenhauff B, Stroebel W, Rassner G, et al. Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment. Br J Dermatol 1999; 141:783-787.
27. Illig L, McCann-Roos U, Klaubert EW, Kunze J, Lacner K, Muller H, et al. Public education in recognizing melanoma. Z Hautkr 1989; 64:537-546, 551-563.
28. Pfahlberg A, Gefeller O, Kolmel KF. Public awareness of malignant melanoma risk factors in Germany. J Epidemiol Community Health 1997; 51:698-700.
29. Volkenandt M, Schmidt M, Konz B, Gummer M, Hein R, Plewig G, et al. Clinical and epidemiological data of patients with malignant melanoma from the Munich Tumor Center 1977-1997. Hautarzt 1999; 50:470-478.
30. Baumert J, Plewig G, Volkenandt M, Schmid-Wendtner MH. Factors associated with a high tumour thickness in patients with melanoma. Br J Dermatol 2007; 156:938-944.
31. Demierre MF, Chung C, Miller DR, Geller AC. Early detection of thick melanomas in the United States: beware of the nodular subtype. Arch Dermatol 2005; 141:745-750.
32. Liu W, Dowling JP, Murray WK, McArthur GA, Thompson JF, Wolfe R, et al. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Arch Dermatol 2006; 142:1551-1558.
33. Bono A, Tolomio E, Bartoli C, Carbone A, Tomatis S, Zurrida S, et al. Metamorphosis of melanoma. Trends in size and thickness of cutaneous melanoma over one decade at the Institute Nazionale Tumori Milano. Tumori 2008; 94:11-13.
34. Lipsker D. Growth rate, early detection, and prevention of melanoma: melanoma epidemiology revisited and future challenges. Arch Dermatol 2006; 142:1638-1640.
35. Abbasi NR, Shaw HM, Rigel DS, Friedman RJ, McCarthy WH, Osman I, et al. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. J Am Med Assoc 2004; 292:2771-2776.
36. Australian Institute of Health and Welfare, http://www.aihw.gov.au. Web site accessed. 17-10-2006.